Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates50,265주2026-06-30 · 증감 -91547주
ACADIA Pharmaceuticals company information
아카디아 파머슈티컬스NASDAQ:ACAD · Nasdaq · Healthcare$19.95+0.30%
2026-10-02 closeACADIA Pharmaceuticals's company information is shown as of 2026-10-02. It is a security listed on Nasdaq, ticker ACAD. There are 14 published related companies.
About this company
ACADIA Pharmaceuticals last closed at $19.95 (+0.30%) on 2026-10-02. Listed on Nasdaq.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Suppliers, competitors and related stocks
- Otsuka HoldingsCustomer
레켐비 관련 제휴 및 상업화 파트너로 연결
- H. LundbeckCustomer
항정신병 치료제 누플라지드 상업화/유통 관련 제휴 파트너
- PfizerCompetitor
중추신경계·정신질환 영역에서 치료제 경쟁
- Eli LillyCompetitor
신경과학·중추신경계 신약 개발 경쟁
- Johnson & JohnsonCompetitor
정신질환·신경과학 치료제 시장의 대형 경쟁사
- AbbVieCompetitor
신경정신과 및 특수의약품 영역에서 경쟁
- TakedaCompetitor
신경과학·희귀질환 파이프라인에서 경쟁
- Neurocrine BiosciencesCompetitor
정신과·신경계 질환 치료제 포트폴리오가 겹침
- Intra-Cellular TherapiesCompetitor
정신분열증·양극성장애 등 중추신경계 치료제 경쟁
- Sunovion PharmaceuticalsCompetitor
정신질환 치료제 시장에서 유사 적응증 경쟁
- AptinyxRelated theme
중추신경계(CNS) 신약 개발 테마의 비교 대상
- Sage TherapeuticsRelated theme
우울증·신경정신과 치료제 개발 테마가 유사
- BiogenRelated theme
알츠하이머·신경과학 영역에서 같은 테마로 연결
- EisaiCustomer
알츠하이머 치료제 상업화 생태계에서 연관된 주요 파트너
Major stocks in the same sector
2026-10-04 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $6M(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy